TAM
QNTM

Tucker Asset Management’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Tucker Asset Management’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,114
Closed -$8.13K – 1064
2025
Q4 		$8.13K Buy
+1,114
New +$12.2K ﹤0.01% 615

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Tucker Asset Management's QNTM Position: Q1 2026 in Review

Tucker Asset Management sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q1 2026, closing a stake of 1,114 shares — an estimated $8.13K sold.

Tucker Asset Management first reported a position in QNTM in Q4 2025 and held it in 1 quarter. The position peaked at $8.13K in Q4 2025. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

  • Tucker Asset Management reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q1 2026 after selling out during the quarter.
  • Tucker Asset Management sold 1,114 Quantum Biopharma Class B Subordinate Voting Shares shares in Q1 2026, an estimated $8.13K.
  • Tucker Asset Management first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2025 and held it in 1 quarter.
  • Tucker Asset Management's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $8.13K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on Tucker Asset Management's 13F filing for Q1 2026, filed 27 Aug 2026.